TransWestTech, Inc. (TWT), is developing a proprietary method for producing large quantities of medical-grade recombinant proteins or peptides, using one of nature's best packages, the egg. TransWestTechÂ’s innovation has outstanding potential to lower the cost of mass vaccinations and to protect troops and civilians against biowarfare agents as well as more common infectious diseases.
